Lack of effect of ranitidine on the disposition of lignocaine

Br J Clin Pharmacol. 1983 Mar;15(3):378-9. doi: 10.1111/j.1365-2125.1983.tb01514.x.

Abstract

Cimetidine has been shown to alter the disposition of lignocaine and other drugs that are highly extracted by the liver. In a placebo controlled study ranitidine (150 mg twice daily) did not alter the elimination half-life, systemic clearance or distribution of lignocaine (mg/kg) in six healthy subjects. The interaction with cimetidine appears to be unrelated to histamine H2-receptor antagonism.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Female
  • Furans / pharmacology*
  • Half-Life
  • Histamine H2 Antagonists / pharmacology*
  • Humans
  • Kinetics
  • Lidocaine / metabolism*
  • Male
  • Ranitidine

Substances

  • Furans
  • Histamine H2 Antagonists
  • Ranitidine
  • Lidocaine